Pfizer is set to raise £2.4 billion after it reduced its stake in the FTSE 100-listed consumer healthcare business Haleon ...

For Haleon, which was spun off from British drugmaker GSK in 2022, the joint venture ... Bactroban and pain relief products Fenbid and Voltaren. Haleon, which will fund the stake acquisition ...

British consumer healthcare company Haleon said on Friday it has agreed to raise its stake in its Chinese joint venture by 33 ...

GSK), the makers of Voltaren Arthritis Pain Gel (diclofenac sodium topical gel, 1%) today revealed new data that uncovers ...

The FTSE 100 index put back some of yesterday’s losses by adding 19.54 points to 8256.49, while the FTSE 250 index stayed ...

A small number of roles have been impacted by organisational changes at Haleon's plant in Dungarvan, Co. Waterford ...

When Sanofi announced last week that it plans to sell a 50% controlling stake of Opella, its consumer helath business, the ...

GSK’s shares rose by as much as 6.5% on Thursday before settling back slightly lower after it agreed a $2.2 billion settlement over lawsuits in the US, which alleged the drugmaker’s now ...

Settlement resolves 80,000 or 93% of pending US cases GSK top gainer on FTSE-100, best one-day gain since Dec 2022 To record 1.8 billion pounds charge in Q3 results Oct 10 (Reuters) - GSK (GSK.L ...